Doherty Clinical Trials accelerates the development of novel medicines and vaccines for key partners and industry clients. Our primary focus is the safety of our participants through the implementation of high-quality and ethical clinical research. We offer capacity to undertake trials in a range of therapeutic areas with a specific focus on clinical trials for infectious diseases, including human infection challenge studies. These specialised studies offer unique opportunities during early-phase clinical development of antimicrobial drugs and vaccines and can accelerate key decision making, save millions of dollars and substantially decrease timelines for clinical development. Our facility is the only unit in Australia specifically commissioned to deliver human challenge trials. All trials are supported by broad networks of clinical trial expertise, including some of the world’s leading hospital clinicians and research scientists.